Faricimab lacks proof of added benefit over comparator therapies for macular edema

  • Post author:
  • Post category:uncategorized

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion.